ESC HF 2026 Clinical Insights: Advancing Cardiovascular Care
Explore concise, expert-led educational activities delivering the latest updates from ESC Heart Failure. This series highlights emerging science, real-world evidence, and evolving treatment strategies across the spectrum of heart failure and cardiovascular-kidney-metabolic disease. Through focused discussions and expert commentary, faculty review key data presentations and their implications for clinical practice and patient outcomes.

1-3 of 3
Finerenone in HFpEF: Key Insights From ESC HF
CardiologyFinerenone in HFpEF: Key Insights From ESC HF
SPIRIT-HF: Does Spironolactone Improve Outcomes in HFpEF and HFmrEF?
CardiologySPIRIT-HF: Does Spironolactone Improve Outcomes in HFpEF and HFmrEF?
Treatment Patterns and MRA Use in Patients with HFmrEF/HFpEF: Insights From FRAME-HF and IRIS HF
CardiologyTreatment Patterns and MRA Use in Patients with HFmrEF/HFpEF: Insights From FRAME-HF and IRIS HF











